API | carbon monoxide

carbon monoxide Report issue

Small molecule Experimental

AACT ChEMBL DrugBank PubChem

Active Ingredient History

NOW

Now

CO or variants may refer to: ^Wikipedia

Chemistry

SMILES: [C-]#[O+]
InChIKey: UGFAIRIUMAVXCW-UHFFFAOYSA-N
Mol. Mass: 28.01
ALogP: -0.04 Partition coefficient
ChEMBL Molecule:
carbon monoxide

More Chemistry

Pharmacology

Mechanism of Action:
- Hemoglobin subunit alpha (Homo sapiens) ^UniProt
- Hemoglobin subunit beta (Homo sapiens) ^UniProt
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

carboneum oxygenisatum | carbon(ii) oxide | carbon monoxide | co

Organizations (30)

Research & Development (30)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (16)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (16)

Anemia, Sickle Cell (Phase 1/Phase 2)

Carbon Monoxide (Phase 1/Phase 2)

Endothelial Cells (Phase 1)

Healthy Volunteers (Phase 1)

Heart Diseases (Phase 1/Phase 2)

Hypertension, Pulmonary (Phase 1/Phase 2)

Idiopathic Pulmonary Fibrosis (Phase 2)

Ileus (Phase 2)

Kidney Transplantation (Phase 2)

Organelle Biogenesis (Phase 1/Phase 2)

Pancreatitis, Chronic (Phase 1/Phase 2)

Pulmonary Diffusing Capacity (Phase 1)

Pulmonary Disease, Chronic Obstructive (Phase 2)

Respiratory Distress Syndrome (Phase 2)

Sepsis (Phase 1)

Smoking (Phase 1)

Overview

Highest Phase: Phase 2
# of Trials: 24
# of Trial Organizations: 30

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue